Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography of the brain, MR spectroscopy, and therapeutic attempts in methylenetetrahydrofolate reductase deficiency

Brain and Development

Volumn 21, Issue 5, 1999, Pages 345-349

  Al Essa, M A ^a   Al Amir, A ^b   Rashed, M ^a   Al Jishi, E ^c   Abutaleb, A ^b   Mobaireek, K ^b   Shin, Y S ^d   Ozand, P T ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

^c SALMANIYA MEDICAL COMPLEX   (Bahrain)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

FDG PET brain scan; Methionine; Methylenetetrahydrofolate reductase deficiency; MR spectroscopy

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE; CYANOCOBALAMIN; FLUORODEOXYGLUCOSE F 18; FOLINIC ACID; HOMOCYSTEINE; METHIONINE;

APNEA; ARTICLE; BLOOD ANALYSIS; BLOOD STAIN; CASE REPORT; CELL CULTURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENZYME DEFICIENCY; FEMALE; HUMAN; IN VITRO STUDY; MUSCLE HYPOTONIA; NEWBORN; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; SKIN FIBROBLAST; TANDEM MASS SPECTROMETRY; URINALYSIS;

BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MASS SPECTROMETRY; METHIONINE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033037018     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(99)00031-5     Document Type: Article

References (10)

1. Ozand, P.T., Rashed, M., Al-Shahwan, S., Al-Saban, E., Sakati, N., Joshi, S., et al. Diagnosis of sulphur amino acids metabolic abnormalities by automated electrospray MS/MS. The 44th ASMS Conference on Mass Spectrometry and Allied Topics, Portland, Oregon, USA, 12-16 May 1996.
2. Shin Y.S., Pilz G., Endres W. Methylenetetrahydrofolate reductase and methyltetrahydrofolate methyltransferase in human fetal tissue and chorionic villi. J Inher Metab Dis. 9:((Suppl. 2)):1986;275-276.
3. Rosenblatt D.S. Inherited disorders of folate transport and metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular bases of inherited disease. 1995;3111 McGraw Hill, New York.
4. Narisawa K., Wada Y., Saito T., Suzuki H., Kudo M. Infantile type of homocystinuria with N5, 10-methylenetetrahydrofolate reductase defect. Tohoku J Exp Med. 121:1977;185-194.
5. Rozen R. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Met Dis. 19:1996;589-594.
6. Shih V.E., Salem M.Z., Mudd S.H., Uhlendorf B.W., Adams R.D. A new form of homocystinuria due to N(5,10)-methylenetetrahydrofolate reductase deficienc. Ped Res. 6:1972;395.
7. Haworth J.C., Dilling L.A., Surtees R.A., Seargeant R.A., Lue-Shing H., Cooper B.A., et al. Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet. 45:1993;572-576.
8. Rashed M.S., Bucknall M.P., Little D., Awad A., Jacob M., Al Amoudi M., et al. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem. 43:1997;1129-1141.
9. Molloy A.M., Orsi B., Kennedy D.G., Kennedy S., Weir D.G., Scott J.M. The Relationship between the activity of methionine synthase and the ratio of S-adenosylmethionine to S-adenosylhomocysteine in the brain and other tissues of the pig. Biochem Pharmacol. 44:1992;1349-1355.
10. Kobayashi K., Nakajima E., Kubo Y., Yasukawa Y., Iwata N. S-adenosyl-L-methionine ameliorates reduced local cerebral glucose utilization following brain ischemia in the rat. Jap J Pharmacol. 52:1990;141-148.